Endometrial-Myometrial Interface: Relationship to Adenomyosis and Changes in Pregnancy
review
OA: closed
CC0
⤵ 90 in-corpus citations
AI-generated summary
This paper describes the endometrial-myometrial interface, its unique features, its disruption during pregnancy and adenomyosis, and the roles of sex steroids and local mediators.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
The endometrial-myometrial interface (EMI) is an important region of the human uterus, which has attracted little research attention. This mucosal-muscular interface has characteristic features when compared with other similar interfaces in the human body. It lacks an intervening tissue layer and as a result, the endometrium sits directly on the myometrium rendering it vulnerable to invasion by the endometrium. Both endometrium and myometrium are sensitive to sex steroids, and their structure and function depend to a large extent on the sex hormonal milieu. Endometrium, which forms one border of the EMI, is a complex tissue consisting of several polarized microenvironments. At a cellular level, sex steroids interact with local mediators secreted by a variety of cell types and are important in maintaining the complex structure and function of the endometrium. Basal endometrium contains prominent aggregates of leukocytes that may be important in controlling local cell growth and function. Myometrium also has a distinct zonal anatomy. The recently described junctional zone differs structurally and functionally from the outer myometrium, although these functions are not yet clearly understood. Embryologically, it originates from müllerian ducts together with endometrium, whereas the outer myometrium has a non-müllerian origin. During early pregnancy, the EMI is disturbed by invading trophoblast. Alterations of myometrial intercellular matrix proteins together with expression of appropriate receptors by the trophoblast seem to regulate this unique interaction. The EMI also is disrupted in adenomyosis. The sequence of events taking place at the EMI during development of this pathology is still debated. Target Audience Obstetricians & Gynecologists, Family Physicians Learning Objectives After completion of this article, the reader will be able to describe the endometrial-myometrial interface, including its structural and functional features, to summarize the embryologic development of the uterus and specifically the endometrial-myometrial interface, and to list examples of clinical situations where the endometrial-myometrial interface is disrupted and how these interactions are regulated.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (56)
- Apoptosis and Ki-67 expression in adenomyotic lesions and in the corresponding eutopic endometrium via openalex
- Cell Proliferation and apoptosis: Detection of apoptosis in human endometriotic tissues via openalex
- Characterization of subendometrial myometrial contractions throughout the menstrual cycle in normal fertile women via openalex
- Epidermal growth factor in human endometrium: proliferative effects in culture and immunocytochemical localization in normal and endometriotic tissues via openalex
- Expression of adhesion molecules in human endometrial vasculature throughout the menstrual cycle via openalex
- Growth factors and growth modulators in human uterine endometrium: their potential relevance to reproductive medicine via openalex
- Is adenomyosis an immune disease? via openalex
- Localization of T Cells, Interferon-Gamma and HLA-DR in Eutopic and Ectopic Human Endometrium via openalex
- Pathologic Findings from the Maryland Womenʼs Health Study: Practice Patterns in the Diagnosis of Adenomyosis via openalex
- Relationship of adenomyosis uteri to endometrial hyperplasia and endometrial carcinoma via openalex
- Smooth muscle differentiation at endometrio-myometrial junction via openalex
- The cyclic pattern of the immunocytochemical expression of oestrogen and progesterone receptors in human myometrial and endometrial layers: characterization of the endometrialsubendometrial unit via openalex
- The elusive adenomyosis of the uterus via openalex
- The elusive adenomyosis of the uterus—revisited via openalex
- The nonsurgical diagnosis of adenomyosis via openalex
- The uterus: in vitro MR-anatomic correlation of normal and abnormal specimens. via openalex
- Ultrastructural changes in uterine myometrium of mice with experimentally-induced adenomyosis via openalex
- Unusual ultrasonographic appearance of the uterus in patients receiving tamoxifen via openalex
- Uterine junctional zone: function and disease via openalex
- W2073730670 via openalex
- W2090012882 via openalex
- W2093047683 via openalex
- W2106195080 via openalex
- W86461427 via openalex
- W2113276741 via openalex
- W2115081018 via openalex
- W2123034006 via openalex
- W2123139933 via openalex
- W2127155035 via openalex
- W2155334311 via openalex
- W2165109616 via openalex
- W2238091929 via openalex
- W2243809168 via openalex
- W2273333468 via openalex
- W2287485666 via openalex
- W2406102853 via openalex
- W4247344887 via openalex
- W2110548184 via openalex
- W143665051 via openalex
- W1571180753 via openalex
- W1632022789 via openalex
- W1848970261 via openalex
- W1916481231 via openalex
- W1973076537 via openalex
- W1979519933 via openalex
- W1997513963 via openalex
- W1997746787 via openalex
- W2018372782 via openalex
- W2031594566 via openalex
- W2033945601 via openalex
- W2035633938 via openalex
- W2038715249 via openalex
- W2046882427 via openalex
- W2051768735 via openalex
- W2052930528 via openalex
- W2058692557 via openalex
Cited by (50)
- The interaction between inflammation and estrogen in adenomyosis : from molecular mechanisms to therapeutic strategies 2026
- Lipidome atlas of human myometrium reveals distinctive lipid signatures associated with adenomyosis: Combination of high-coverage lipidomics and mass spectrometry imaging 2025
- The Role of M1 and M2 Macrophages in the Progression of Endometrial Hyperplasia to Endometrioid Adenocarcinoma 2025
- Systematic review and meta-analysis of adverse pregnancy outcomes with different types of adenomyosis 2025
- Analysis of Dysmenorrhea-Related Factors in Adenomyosis and Development of a Risk Prediction Model 2024
- Histopathological characteristics of adenomyosis: structure and microstructure 2023
- Proliferative characteristics of eutopic and ectopic endometrium in adenomyosis using AgNOR technology 2023
- Effects of localization of uterine adenomyosis on clinical features and pregnancy outcome 2023
- Establishment of a Novel Mouse Model of Adenomyosis Suitable for Longitudinal and Quantitative Analysis and Perinatal Outcome Studies 2022
- Pituitary suppression with GnRH agonists before ART may be insufficient to treat women with severe adenomyosis 2022
- Establishment of a novel mouse model of adenomyosis suitable for longitudinal and quantitative analysis and perinatal outcome studies 2022
- Altered Expression of Interleukin-18 System mRNA at the Level of Endometrial Myometrial Interface in Women with Adenomyosis 2022
- Classifications of Adenomyosis and Correlation of Phenotypes in Imaging and Histopathology to Clinical Outcomes: a Review 2022
- Unveiling the Pathogenesis of Adenomyosis through Animal Models 2022
- Integrative metabolomic profiling reveals aberrations in myometrium associated with adenomyosis: a pilot study 2022
- RETROSPECTIVE ANALYSIS OF CHANGING TRENDS IN PRESENTATION AND MANAGEMENT OF ADENOMYOSIS 2022
- Endometriosis: A Retrospective Analysis of Clinical Data from a Cohort of 4,083 Patients, With Focus on Symptoms 2022
- Cardiometabolic profiles in women with adenomyosis 2022
- Establishment of a novel mouse model of adenomyosis suitable for longitudinal and quantitative analysis and perinatal outcome studies 2022
- Ectopic Endometrium: The Pathologist’s Perspective 2021
- The myometrial‐cervical ratio (MCR): Assessing the diagnostic accuracy of a novel ultrasound measurement in the diagnosis of adenomyosis 2021
- The Pathogenesis of Adenomyosis 2021
- Investigation of the role of platelets in the aetiopathogenesis of adenomyosis 2021
- Proposal for adenomyosis classification based on the endometriosis phenotype 2021
- Benign gynecologic lesions 2021
- Adenomyosis pathogenesis: insights from next-generation sequencing 2021
- Diagnosing adenomyosis: an integrated clinical and imaging approach 2020
- Adenomyosis: Mechanisms and Pathogenesis 2020
- Relationship between adenomyosis and endometriosis; Different phenotypes of a single disease? 2020
- Epidemiology of Adenomyosis 2020
- Adenomyosis: Disease, uterine aging process leading to symptoms, or both? 2020
- Immunological changes associated with adenomyosis: a systematic review 2020
- A critical review of recent advances in the diagnosis, classification, and management of uterine adenomyosis 2019
- Classification and Reporting Systems for Adenomyosis 2019
- CONTROVERSIAL ISSUES OF RADIOLOGIC DIAGNOSIS OF ADENOMYOSIS IN REPRODUCTIVE LOSSES 2019
- Sonographic classification and reporting system for diagnosing adenomyosis 2018
- Coexistence of adenomyosis, adenocarcinoma, endometrial and myometrial lesions in resected uterine specimens 2018
- Myofibroblasts Are Evidence of Chronic Tissue Microtrauma at the Endometrial-Myometrial Junctional Zone in Uteri With Adenomyosis 2017
- Uterine Stem Cells and Their Future Therapeutic Potential in Regenerative Medicine 2017
- Treatment options and reproductive outcome for adenomyosis-associated infertility 2017
- Effects of Jiawei Shaoyao‐Gancao Decoction and Its Drug‐Containing Serum on Proliferation, Apoptosis, and Ultrastructure of Human Adenomyosis Foci Cells 2017
- Down-regulation of tumor suppressor PDCD4 expression in endometrium of adenomyosis patients 2016
- Repeatability of Junctional Zone Measurements Using 3‐Dimensional Transvaginal Sonography in Healthy Fertile Women 2016
- The Role of the Myometrium in Adenomyosis 2015
- The Incidence and Clinical Significance of Adenomyosis 2015
- The Pathophysiology of Adenomyosis 2015
- Adenomyosis: A Clinical Review of a Challenging Gynecologic Condition 2015
- Blocking IL-22, a potential treatment strategy for adenomyosis by inhibiting crosstalk between vascular endothelial and endometrial stromal cells. 2015
- L-22 enhances the invasiveness of endometrial stromal cells of adenomyosis in an autocrine manner. 2014
- Adenomyosis and Its Effect on Reproductive Outcomes 2014
Source provenance
- europepmc
- last seen: 2026-06-12T06:13:51.797165+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:13:36.046895+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK